Cell Wall News and Research

RSS

Researchers discover new candidate for raw material synthesis through gene transfer

Cyanobacteria hardly need any nutrients and use the energy of sunlight. Bathers are familiar with these microorganisms - often incorrectly called "blue-green algae" - as they often occur in waters.

2 Jul 2020

Irresistin: a ‘poison arrow’ to defeat antibiotic resistance

News-Medical speaks to Dr. James Martin and Dr. Zemer Gitai from Princeton University about their research which led to the discovery of a new antibiotic.

1 Jul 2020

Antihypotensive agent for sepsis disrupts the immune system, increases susceptibility to infections

Patients who go into shock caused by sepsis (septic shock) are treated with the antihypotensive agent norepinephrine.

11 Jun 2020

Chemotherapy and cancer join together to cause neuropathy

Contrary to common medical guidance, chemotherapy does not appear to be the only culprit in neuropathy, a neurological side effect of cancer treatment, a new study says. Cancer itself contributes heavily, too, and the stresses on neurons appear far worse than the sum of the two causes.

8 Jun 2020

Discovery of new killing mechanism could help design improved teixobactin-based drugs

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin - a new class of potent natural antibiotic capable of killing superbugs.

5 Jun 2020

New platform can speed up the development of novel antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly.

4 Jun 2020

Drug Teixobactin shows promise against drug-resistant superbugs

Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, “The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study,” was published in the latest issue of the journal Therapeutics and Prevention.

4 Jun 2020

Virginia Tech researcher wins $661,216 grant to study Lyme arthritis

With a $661,216 grant from the Steven & Alexandra Cohen Foundation, Brandon Jutras, an assistant professor of biochemistry in the Virginia Tech College of Agriculture and Life Sciences, will study Lyme arthritis, including the cellular component that contributes to it.

22 May 2020

Researchers identify intermediate pathway that modifies synthesis and structure of cell wall

An accumulation of an unexpected intermediate of the peptidoglycan recycling pathway that is able to modulate the synthesis and structure of the cell wall, has been found by researchers at Umeå University, Sweden.

19 May 2020

Researchers develop new method to study the effect of long-term oxygen deficiency

Researchers at Luleå University of Technology have developed a method to study how muscle cells in the blood vessels of the lung, permanently contract because of long-term oxygen deficiency.

15 May 2020

Discovery heralds a new strategy in the hunt for antibiotics

Scientists have identified a key process in the way bacteria protect themselves from attack - and it heralds a new strategy in the hunt for antibiotics.

3 May 2020

Research: Peptide makes older antibiotics effective again at doses 100 times lower than usual

A peptide renders older antibiotics effective again at doses 100 times lower than the common dosage, as shown by research from örebro University.

22 Apr 2020

Australian plant that produces antibodies may help in coronavirus vaccine production

As the world reels from the rising number of cases of COVID-19 disease caused by SARS-CoV-2, an Australian scientist, Prof. Peter Waterhouse from Laboratory of Molecular Genetics (LMG) at Queensland University of Technology (QUT), is working with a native plant from Australia that shows potential in the fight against SARS-CoV-2.

7 Apr 2020

Antibiotic blocks the integration of building blocks into the cell wall of pathogens

One of the last arrows in the quiver in the fight against dangerous bacteria is the reserve antibiotic daptomycin.

21 Mar 2020

New bacteria-killing light-activated coating

A new antimicrobial coating that can be activated by light has been reported by researchers in the journal Nature Communications, in March 2020. The coating can be used to prevent transmission from computer and phone screens and keyboards, the inside of catheters, and breathing tubes. All these are significant routes of healthcare-associated infections (HCAIs).

5 Mar 2020

Newly discovered antibiotics kill bacteria differently

Antibiotic resistance is a growing public health problem across the globe, with many diseases becoming harder to treat. Now, a newly discovered antibiotic group shows promise in the fight against superbugs as it has a unique way of killing bacteria.

13 Feb 2020

Researchers discover antibiotics with unique approach to attacking bacteria

A new group of antibiotics with a unique approach to attacking bacteria has been discovered, making it a promising clinical candidate in the fight against antimicrobial resistance.

12 Feb 2020

Study identifies potential drug target and way to alleviate cerebral malaria

Scientists have identified a key molecule involved in the development of cerebral malaria, a deadly form of the tropical disease. The study identifies a potential drug target and way forward toward alleviating this condition for which few targeted treatments are available.

9 Feb 2020

Bandages sense infections, change color, treat infection

In what reads like science fiction, a new study published in the journal ACS Central Science reports the development of bandages that detect the presence of bacteria in wounds and change color, depending on whether they are drug-sensitive or drug-resistant. This is an important step in helping patients recover better.

29 Jan 2020

Do biologists and physicists approach AFM differently?

This was the question at the forefront of my mind as I attended the Linz Winter Workshop back in February. Do biologists and physicists approach AFM differently and, does it matter?

From Nu Nano Ltd 28 Jan 2020